Loss of Trabid, a New Negative Regulator of the Drosophila Immune-Deficiency Pathway at the Level of TAK1, Reduces Life Span
Open Access
- 20 February 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 10 (2) , e1004117
Abstract
A relatively unexplored nexus in Drosophila Immune deficiency (IMD) pathway is TGF-beta Activating Kinase 1 (TAK1), which triggers both immunity and apoptosis. In a cell culture screen, we identified that Lysine at position 142 was a K63-linked Ubiquitin acceptor site for TAK1, required for signalling. Moreover, Lysine at position 156 functioned as a K48-linked Ubiquitin acceptor site, also necessary for TAK1 activity. The deubiquitinase Trabid interacted with TAK1, reducing immune signalling output and K63-linked ubiquitination. The three tandem Npl4 Zinc Fingers and the catalytic Cysteine at position 518 were required for Trabid activity. Flies deficient for Trabid had a reduced life span due to chronic activation of IMD both systemically as well as in their gut where homeostasis was disrupted. The TAK1-associated Binding Protein 2 (TAB2) was linked with the TAK1-Trabid interaction through its Zinc finger domain that pacified the TAK1 signal. These results indicate an elaborate and multi-tiered mechanism for regulating TAK1 activity and modulating its immune signal. Chronic activation of immune responses results in health problems including gastrointestinal infections, metabolic imbalances and inflammatory bowel diseases that may lead to colorectal cancer. Central to this, is the balance of activation/restriction of nuclear factor-κB (NF-κB) during innate immune responses. To study signaling through NF-κB, we use the fruit fly Drosophila melanogaster as a genetically tractable model system that reflects human biology (due to the evolutionary conservation between innate immunity in flies and mammals), while reducing the complexity of the human disease of interest. We have found a new negative regulator of the Drosophila NF-κB pathway named Trabid. Its loss released the pathway and resulted in constitutive immune activation both in the gut as well as in the whole fly. This spontaneous immune activation reduced life span in the absence of infection, especially when it was combined with loss of another known negative regulator of the same pathway, a protein named Pirk. Stem cell activity in the gut in a pirk;trabid double mutant was found to be significantly increased, as the gut was trying to balance enterocyte loss. Trabid was acting at the level of TGF-beta Activating Kinase 1 (TAK1), which triggers both immunity and cell death.Keywords
This publication has 49 references indexed in Scilit:
- Invasive and indigenous microbiota impact intestinal stem cell activity through multiple pathways in DrosophilaGenes & Development, 2009
- The emerging complexity of protein ubiquitinationBiochemical Society Transactions, 2009
- The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathologyTrends in Immunology, 2009
- Two roles for theDrosophilaIKK complex in the activation of Relish and the induction of antimicrobial peptide genesProceedings of the National Academy of Sciences, 2009
- Cytokine/Jak/Stat Signaling Mediates Regeneration and Homeostasis in the Drosophila MidgutCell, 2009
- Targeting the ubiquitin system in cancer therapyNature, 2009
- Rudra Interrupts Receptor Signaling Complexes to Negatively Regulate the IMD PathwayPLOS Pathogens, 2008
- PIMS Modulates Immune Tolerance by Negatively Regulating Drosophila Innate Immune SignalingCell Host & Microbe, 2008
- Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chainsGenes & Development, 2008
- ADrosophilaortholog of the human cylindromatosis tumor suppressor gene regulates triglyceride content and antibacterial defenseDevelopment, 2007